FDA Draft Guidance on Patient Preference Information in the TPLC: Practical Considerations
The new article pays additional attention to the specific practical considerations pertaining to the use of patient preference information.
The new article pays additional attention to the specific practical considerations pertaining to the use of patient preference information.
The new article highlights the aspects related to obtaining feedback from the authority in order to ensure compliance with the relevant regulatory requirements.
The new article is dedicated to additional considerations to be taken into account when using patient preference information associated with medical devices intended to be marketed and used in the US.
The new article highlights the key points related to the actual implementation of the information collected from patients in the form of feedback.
The new article outlines the key points regarding patient preference information and its use in the context of the product lifecycle.
The article outlines the basics of chemical analysis in the context of biocompatibility of medical devices.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report